Kursprognose für GT Biopharma Inc (GTBP)

$4.440

-0.098 (-2.20%)Zum Schluss

Kursprognosen

1-Day Price Prediction

-0.19%

1-Week Prediction

-0.67%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.

Loading chart…

GTBP-Prognose durch Analyse ähnlicher Charts

Alphio's GTBP stock price prediction model matches the current GT Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.43 (-0.19%). The 1-week path is $4.41 (-0.67%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Soll ich GT Biopharma Inc-Aktien kaufen?

GT Biopharma Inc is not a good buy right now due to a significant net loss of $28.4 million for FY2025 and a current RSI of 23.39, indicating oversold conditions but also potential ongoing weakness. The stock has dropped 78.26% year-to-date, reflecting severe market challenges and investor sentiment issues.

GTBP schloss am Friday bei $4.44, nachdem der Kurs -2.20% fallen

GT Biopharma Inc (GTBP) last closed at $4.4400001, losing -2.20%. These facts feed the 1-day and 1-week GTBP price prediction above.

Prognose-Treiber

Die Prognose-Treiber von GT Biopharma Inc (GTBP) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Saisonalitätsanalyse für GTBP

Historically the probability of a positive November return for GTBP is 0.00%. June offers the highest probability of a positive month at 16.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…